View in EDS

Programmed Cell Death Protein 1-Interleukin-2 Bispecific Agents for Cancer Therapy.

Saved in:
Bibliographic Details
Title: Programmed Cell Death Protein 1-Interleukin-2 Bispecific Agents for Cancer Therapy.
Authors: Xu C; Institute of Psychiatry and Neuroscience, Henan Medical University, Xinxiang, China., Yan T; Institute of Psychiatry and Neuroscience, Henan Medical University, Xinxiang, China., Wen S; Gastroenterology Department, Henan Health Commission Key Laboratory of Gastrointestinal Cancer Prevention and Treatment, Xinxiang, China., Wu C; Institute of Psychiatry and Neuroscience, Henan Medical University, Xinxiang, China., Chang T; Gastroenterology Department, Henan Health Commission Key Laboratory of Gastrointestinal Cancer Prevention and Treatment, Xinxiang, China. ctminmail@163.com., Kong E; Institute of Psychiatry and Neuroscience, Henan Medical University, Xinxiang, China. eykong2012@163.com.; The Second Affiliated Hospital of Henan Medical University, Xinxiang, China. eykong2012@163.com., Liu H; Institute of Psychiatry and Neuroscience, Henan Medical University, Xinxiang, China. liuhuicong@xxmu.edu.cn.; The Second Affiliated Hospital of Henan Medical University, Xinxiang, China. liuhuicong@xxmu.edu.cn.
Source: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy [BioDrugs] 2026 May; Vol. 40 (3), pp. 459-478. Date of Electronic Publication: 2026 Apr 13.
Publication Type: Journal Article; Review
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9705305 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-190X (Electronic) Linking ISSN: 11738804 NLM ISO Abbreviation: BioDrugs Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41973150
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Programmed Cell Death Protein 1-Interleukin-2 Bispecific Agents for Cancer Therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Xu+C%22">Xu C</searchLink>; Institute of Psychiatry and Neuroscience, Henan Medical University, Xinxiang, China.<br /><searchLink fieldCode="AU" term="%22Yan+T%22">Yan T</searchLink>; Institute of Psychiatry and Neuroscience, Henan Medical University, Xinxiang, China.<br /><searchLink fieldCode="AU" term="%22Wen+S%22">Wen S</searchLink>; Gastroenterology Department, Henan Health Commission Key Laboratory of Gastrointestinal Cancer Prevention and Treatment, Xinxiang, China.<br /><searchLink fieldCode="AU" term="%22Wu+C%22">Wu C</searchLink>; Institute of Psychiatry and Neuroscience, Henan Medical University, Xinxiang, China.<br /><searchLink fieldCode="AU" term="%22Chang+T%22">Chang T</searchLink>; Gastroenterology Department, Henan Health Commission Key Laboratory of Gastrointestinal Cancer Prevention and Treatment, Xinxiang, China. ctminmail@163.com.<br /><searchLink fieldCode="AU" term="%22Kong+E%22">Kong E</searchLink>; Institute of Psychiatry and Neuroscience, Henan Medical University, Xinxiang, China. eykong2012@163.com.; The Second Affiliated Hospital of Henan Medical University, Xinxiang, China. eykong2012@163.com.<br /><searchLink fieldCode="AU" term="%22Liu+H%22">Liu H</searchLink>; Institute of Psychiatry and Neuroscience, Henan Medical University, Xinxiang, China. liuhuicong@xxmu.edu.cn.; The Second Affiliated Hospital of Henan Medical University, Xinxiang, China. liuhuicong@xxmu.edu.cn.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229705305%22">BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy</searchLink> [BioDrugs] 2026 May; Vol. 40 (3), pp. 459-478. <i>Date of Electronic Publication: </i>2026 Apr 13.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9705305 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-190X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211738804%22">11738804 </searchLink><i>NLM ISO Abbreviation: </i>BioDrugs <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41973150
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40259-026-00769-x
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 459
    Titles:
      – TitleFull: Programmed Cell Death Protein 1-Interleukin-2 Bispecific Agents for Cancer Therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Xu C
      – PersonEntity:
          Name:
            NameFull: Yan T
      – PersonEntity:
          Name:
            NameFull: Wen S
      – PersonEntity:
          Name:
            NameFull: Wu C
      – PersonEntity:
          Name:
            NameFull: Chang T
      – PersonEntity:
          Name:
            NameFull: Kong E
      – PersonEntity:
          Name:
            NameFull: Liu H
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2026 May
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1179-190X
          Numbering:
            – Type: volume
              Value: 40
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
              Type: main
ResultId 1